American Journal of Psychiatry
- Volume 173
- Number 8
- August 2016
Editorials
Clinical Case Conference
Perspectives in Global Mental Health
Reviews and Overviews
Publication date: 03 May 2016
Pages771–780How should DSM criteria relate to the disorders they are designed to assess? To address this question empirically, the author examines how well DSM-5 symptomatic criteria for major depression capture the descriptions of clinical depression in the post-...
https://doi.org/10.1176/appi.ajp.2016.15121509Articles
Publication date: 03 May 2016
Pages781–789Objective: Adolescents who regularly use marijuana may be at heightened risk of developing subclinical and clinical psychotic symptoms. However, this association could be explained by reverse causation or other factors. To address these limitations, the ...
https://doi.org/10.1176/appi.ajp.2016.15070878Publication date: 22 April 2016
Pages790–798Objective: The authors assessed 1) the overall risk of death among cannabis users compared with nonusers and the extent to which psychosis affects excess mortality; 2) mortality among persons with psychotic disorders and the extent to which cannabis use ...
https://doi.org/10.1176/appi.ajp.2016.14050637Publication date: 24 May 2016
Pages799–806Objective: Cigarette smoking during pregnancy is a major public health problem leading to adverse health outcomes and neurodevelopmental abnormalities among offspring. Its prevalence in the United States and Europe is 12%–25%. This study examined the ...
https://doi.org/10.1176/appi.ajp.2016.15060800Publication date: 03 May 2016
Pages807–815Objective: Both preclinical studies and clinical trials have indicated that the combination of a selective serotonin reuptake inhibitor (SSRI) and a statin may have superior antidepressant effects compared with SSRI treatment alone. The authors sought to ...
https://doi.org/10.1176/appi.ajp.2016.15040463Publication date: 08 April 2016
Pages816–826Objective: Ketamine, an N-methyl-d-aspartate glutamate receptor antagonist, has demonstrated a rapid-onset antidepressant effect in patients with treatment-resistant depression. This study evaluated the efficacy of twice- and thrice-weekly intravenous ...
https://doi.org/10.1176/appi.ajp.2016.16010037Publication date: 04 March 2016
Pages827–835Objective: The authors sought to evaluate the efficacy and safety of ABT-126, a selective α7 nicotinic receptor partial agonist, in stable patients with schizophrenia. Method: A 12-week, double-blind, placebo-controlled, parallel-group phase 2 study was ...
https://doi.org/10.1176/appi.ajp.2015.15010093Letters to the Editor
Book Forum
APA Official Actions
Publication date: 01 August 2016
Pages845–852The following is an edited version of the 2015 Report of the American Board of Psychiatry and Neurology, Inc. The full report can be obtained from the American Board of Psychiatry and Neurology (www.abpn.com).
https://doi.org/10.1176/appi.ajp.2016.1730801Past Issues
View Issues Archive
Vol. 181 | No. 12
Vol. 181 | No. 11
Vol. 181 | No. 10
